Early diagnosis of a tumour is a major problem in the treatment of cancer. Recent technological advances have given new tools to the clinician, and in this review four diagnostic approaches are detailed – staging of lung cancer by computed tomography (CT), radiation therapy planning with CT, follow-up with magnetic resonance spectroscopy and follow-up of colorectal malignancies with positron emission tomography. The present status and future prospects of each method are discussed.
Get full access to this article
View all access options for this article.
References
1.
BerberichW., KayserK., SchnabelK. and van KaickG., ct-Volumetrie bei intrathorakalen Raumforderungen. Strahlentherapie160, 605–611 (1984).
2.
KönigR., van KaickG., LüllichG. and Vogt-MoykopfI.. Computertomographische Beurteilung mediastinaler Lymphknoten beim Bronchialkarzinom. RöFo. 138, 647–792 (1983).
3.
Beyer-EnkeS. A., GörichJ., MüllerM., TüngerthalS. and van KaickG., Der Wert der intravenösen Kontrastmittelinjektion für die thorakale Computertomographie. Röntgenpraxis41, 219–225 (1988).
4.
KönigR., van KaickG., CloriusJ. H. and Vogt-MoykopfI., Computed tomography for staging bronchogenic carcinoma. Eur. J. Radiol. 5, 91–93 (1985).
5.
DringsP., RiziB., AbelU. and van KaickG., Die Inzidenz von Hirnmetastasen beim kleinzelligen Bronchialkarzinom. Prax. Klin. Pneumol. 41, 695–696 (1987).
6.
GörichJ., Beyer-EnkeS. A., FlentjeM., ZunaI.I. Vogt- Moykopf and G. van Kaick, Evaluation of recurrent bronchogenic carcinoma by computed tomography. (Submitted to Clinical Imaging).
7.
KönigR., GademannG., van KaickG., ZabelJ., LorenzW. J. and Vogt-MoykopfI., Magnetresonanztomographie (mrt) und Computertomographie (ct) bei Bronchialkarzinomen. RöFo. 144, 377–498 (1986).
8.
MunzenriderJ. F., PilepichM., Renne-FerraroJ. B., TchakarovaI. and CarterB. I., Use of body scanner in radiotherapy treatment planning. Cancer40, 170–179 (1977).
9.
BadcockP. C., The value of computed tomography in planning radiotherapy of intra-thoracic tumours. Strahlentherapie160, 26–30 (1984).
10.
GoiteinM., AbramsM., RowellD., PollariH. and WilesJ., Multi-dimensional treatment planning: II. Beam's eye view, back projection and projection through ct-scans. Int. J. Rad. Oncol. Biol. Phys. 9, 777–787 (1983).
11.
SchlegelW., ScharfenbergH. and LorenzW. J., Calculation of Dose Distributions From CT-images. In: GarsouJ.(Ed.), Comptes Rendus of International Symp. on Fundamentals in Technical Progress, II. 4.1.-II. 4.32. Presses universitaire de Liege, Liege (1979).
12.
SturmV, KoberB., HöverK. H., SchlegelW., BoeseckeR., PastyrO., HartmannG. H., SchabbertS., WinkelK. zum, KunzeS. and LorenzW. J., Stereotactic percutaneous single dose irradiation of brain metastases with a linear accelerator. Int. J. Rad. Oncol., Biol. Phys. 13, 279–282 (1987).
13.
BauerB., SturmV., SchlegelW. and LorenzW. J., Computerized optimization of I125 implants in brain tumours. Int. J. Rad. Oncol. Biol. Phys. 14, 1013–1023 (1988).
14.
FowlerJ. F., Scientific perspectives on recent progress in radiation oncology. Int. J. Rad. Oncol. Biol. Phys. 12, 709–712 (1985).
15.
SuitH. D. and WestgateS. J., Impact of improved local control on survival. Int. J. Rad. Oncol. Biol. Phys. 12, 453–458 (1985).
16.
SchlegelW., New Trends in Computer-Assisted Radiotherapy with Conventional Radiation. In: BannaschP.(Ed.), Cancer Therapy, Springer-Verlag, Berlin-Heidelberg-New York, pp. 37–48 (1989).
17.
ChinL. M., KijewskiP. K., SvenssonG. K., ChaffeyJ. T., LeveneM. N. and BjärngardB. E., A computer controlled radiation therapy machine for pelvic and para-aortic nodal areas. Int. J. Rad. Oncol. Biol. Phys. 7, 61–70 (1981).
18.
SchadL. R., BoeseckeR., SchlegelW., HartmannG., SturmV., StraussL. G. and LorenzW. J., Three dimensional image correlation of ct, mr and pet studies in radiotherapy treatment planning of brain tumors. J. Computer Assisted Tomography11, 948–954 (1987).
19.
SchlegelW., ScharfenbergH., BaderR., HartmannG., SchnabelK. and LorenzW. J., Computer algorithms for calculation of isodose distributions from ct-matrices. Brit. J. Radiol. Suppl. 15, 118–121 (1981).
20.
SuitH. D., BechtJ., LoengJ., StracherM., WoodW. C., VerheyL. and GoiteinM., Potential for improvement in radiation therapy. Int. J. Rad. Oncol. Biol. Phys. 14, 777–786 (1988).
21.
SostmanH. D., ArmitageI. M. and FischerJ. J., nmr in Cancer: I. High resolution spectroscopy of tumors. Magnet. Reson. imag. 2, 265–278 (1984).
22.
SemmlerW., GademannG., Bachert-BaumannP., ZabelH.-J., LorenzW.-J. and van KaickG., Monitoring human tumor response to therapy by means of 31P-mr spectroscopy. Radiology166, 533–539 (1988).
23.
SemmlerW., GademannG., Bachert-BaumannP.et aliIn vivo 31Phosphor-Spektroskopie von Tumoren: prä intra- und posttherapeutisch. Fortschr. Röntgenstr. 149, 369–377 (1988).
24.
SemmlerW., GademannG., SchlagP., P. Bachert-Baumann et al., Impact of hyperthermic regional perfusion therapy on cell metabolism of malignant melanoma monitored by31 P mr spectroscopy. Magnet. Reson. Imag. 6, 335–340.
25.
SemmlerW., GademannG., Bachert-BaumannP., ZabelH.-J., LorenzW.-J. and van KaickG., Therapieverlaufskon-trolle nach Chemotherapie an Tumoren des Menschen mit Hilfe der in vivo 31P-Spektroskopie, inDigitale Bildgebende Verfahren, Interventionelle Verfahren, Integrierte digitale Radiologie, SchneiderG. H. and VoglerE.(Eds), pp. 15–23. Springer-Verlag, Berlin (1988).
26.
ZabelH.-J., BaderR., GehrigJ. and LorenzW. J., High-quality mr imaging using flexible transmission line resonators. Radiology165, 857–859 (1987).
27.
OberhänsliR. D., JonesD. Hilton, BoreP. J., HandsL. J., RamplingB. P. and RaddaG. K., Biochemical investigation of human tumors in vivo with phosphorus-31 magnetic resonance spectroscopy. Lancet2, 8–11 (1986).
28.
SemmlerW. and HullW., German Cancer Research Centre, Unpublished material. Heidelberg, frg.
29.
BarfussH., DürrW., FischerH., HentschelD. and LadebeckR., In vivo Magnetic resonance spectroscopy of humans with a 4.0 tesla whole-body magnet, nmr in Biomedicine (submitted).
30.
BruhnH., FrahmJ., GyngellM. L., MerboldtK. D., HänickeW., SauterR. and HamburgerC., Noninvasive differentiation of tumors using localized 1H nmr spectroscopy in vivo: initial experience in patients with cerebral tumors. Radiology(in press).
31.
WolfW., AlbrightM. J., SilverM. S., WeberH., ReichardtU. and SauterR., Fluorine-19 nmr spectroscopic studies of the metabolism of 5-fluorouracil in the liver of patients undergoing chemotherapy. Magnet. Reson. Imag. 5, 165–169 (1987).
32.
SemmlerW., Bachert-BaumannP., GückelF., LehnerB., SchlagP. and van KaickG., In vivo 19F magnetic resonance spectroscopy: realtime follow-up of 5-fluorouracil metabolism in tumor patients after intraarterial administration. Magnet. Reson. Imag. 7(S), 29 (1989).
33.
SemmlerW., Bachert-BaumannP., GückelF., ErmarkF., SchlagP., LorenzW. J. and van KaickG., In vivo 19F magnetic resonance spectroscopy: realtime follow-up of 5-fluorouracil metabolism in the liver of tumor patients. Radiology(submitted).
34.
JueT., RothmanD. L., TavitianB. A. and ShulmanR. G., 13C nmr Hepatic glycogen repletion study in man. 7th Annual Meeting of theSociety of Magnetic Resonance in Medicine, San Francisco, 20–26August, 1988. Abstracts1, 248 (1988).
35.
Di ChiroG., OldfieldE. and BairamianD.et al., In vivo glucose utilization of tumors of the brain stem and spinal cord, inPositron Emission Tomography, GreitzT., IngvarD. H. and WidenL.(Eds), pp. 351–361. Raven Press, New York (1985).
36.
MatsuzawaT., FukudaH., AbeY., et al., Current and future aspects of cancer diagnosis with positron emission tomography: biological and clinical aspects, inProceedings of the International Symposium on Current and Future Aspects of Cancer Diagnosis with Positron Emission Tomography. Sendai, 14–18October, pp 1–23 (1985).
37.
GoodmanM. M., ElmahehD. R., MerkL., et al., 18F-2 and 3-fluorodeoxy-D-glucose as potential diagnostic tracers for tumors. J. Nucl. Med. P37 (abstr.) (1981).
38.
PaulR., JohanssonR., KiuruA., et al., Imaging of canine cancers with 18F-2-fluoro-2-deoxy-D-glucose (fdg) suggests further applications for cancer imaging in man. Nucl. Med. Comm. 5, 641–646 (1984).
39.
SomP., AtkinsH. L., BandoypadhyayD., et al., A fluorinated glucose analog, 2-fluoro-2-deoxy-D-glucose (F): nontoxic tracer for rapid tumor detection. J. Nucl. Med. 21, 670–675 (1980).
40.
WeberG. and CanteroA., Glucose-6-phosphatase activity in normal, precancerous, and neoplastic tissues. Cancer Res. 15, 105–108 (1955).
41.
ZanzonicoP. B., BiglerR. E., LeonardR. W. and SacksW., The enzymatic basis of the biodistribution of fdg: implications for tumor imaging. J. Nucl. Med., P64 (abstr.) (1985).
